In vitro and in vivo studies showed that the conjugated PTX, RAP or MIX–M micelles led to the treatment of ovarian cancer through both cytotoxic effects to cancer cells and simultaneous angiogenesis inhibition. The gene discussed is LRPAP1; the disease is ovarian cancer.